| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | FLJ37201 |
| Uniprot No | 0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-199aa |
| 氨基酸序列 | MKNRKTLHRAKNEDLDPVLIEWVRQQRSKDTPLTGLLVVKQARIYHEELNFEGECEYSGGWLQKFKKCLGIKYLQICCEKASPDDEATENYIDEFAKVISDENLSPEQIYSADETALYWCYVPRKTLTMANKRATTDVKDTKQKLTVLECANAAGTHKIKLAVIGNSLYPRCLKGVHNLPVHCYAHKKASVTGNLFQLV |
| 分子量 | 47.8 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
由于FLJ37201蛋白的相关研究较为罕见，且可能属于尚未充分探索的基因/蛋白类别，以下为基于假想文献的概括性示例(实际文献需通过专业数据库核实)：
---
1. **文献名称**：**Characterization of Recombinant Human FLJ37201 Protein Expression in HEK293 Cells**
**作者**：Zhang L et al.
**摘要**：研究通过哺乳动物表达系统(HEK293)成功表达重组人FLJ37201蛋白，纯化后分析了其理化性质及结构稳定性，表明该蛋白可能在细胞代谢中具有潜在功能。
2. **文献名称**：**Functional Analysis of FLJ37201 in the Regulation of Wnt/β-catenin Signaling**
**作者**：Kim S et al.
**摘要**：发现FLJ37201蛋白通过与β-catenin相互作用，负调控Wnt信号通路，可能成为癌症治疗的靶点。研究采用重组蛋白进行体外结合实验和细胞模型验证。
3. **文献名称**：**FLJ37201 Gene Cloning and Its Recombinant Protein Antibody Development**
**作者**：Wang Y et al.
**摘要**：报道了FLJ37201基因的克隆策略及重组蛋白抗体制备，用于免疫组化检测，揭示其在肝组织中高表达，提示与肝脏疾病可能相关。
---
**注意**：
1. 以上文献为示例，**实际研究中可能缺乏直接相关数据**，建议通过 **NCBI Gene/PubMed** 查询最新进展。
2. FLJ37201可能已更名或归类，需在基因数据库(如 **UniProt**)中确认其ID(如ENSG00000123456)。
3. 若研究较少，可扩展至其所在基因家族(如含保守结构域的蛋白)或相关通路文献。
Recombinant human FLJ37201 protein is a genetically engineered protein derived from the FLJ37201 gene, which encodes a functionally uncharacterized protein in humans. Initially identified through genomic and transcriptomic sequencing projects, FLJ37201 is classified as a hypothetical or putative protein due to limited experimental validation of its biological roles. It is predicted to be a cytoplasmic or secreted protein based on sequence analysis, lacking well-defined structural domains or motifs that link it to specific molecular pathways. Bioinformatic studies suggest potential involvement in cellular metabolism, protein-protein interactions, or regulatory processes, though these hypotheses require empirical confirmation.
The recombinant form is typically produced in heterologous expression systems like Escherichia coli or mammalian cell lines to enable functional studies. Purification tags (e.g., His-tag) are often incorporated to facilitate isolation and detection. Current research focuses on elucidating its physiological functions, subcellular localization, and potential associations with diseases through techniques like protein interaction mapping, enzyme activity assays, and gene knockout models. Its recombinant version also serves as an antigen for antibody development and diagnostic tool optimization. The limited understanding of FLJ37201 highlights its status as a novel target for exploratory research in proteomics and functional genomics. Further characterization may uncover roles in cellular homeostasis, disease mechanisms, or therapeutic applications.
×
